Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1984-10-01
1987-05-05
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514223, 514248, 514336, 514420, 514423, 549 10, A61K 3139, C07D32702
Patent
active
046633073
ABSTRACT:
Novel 6H-dibenz[b,e][1,4]oxathiepin derivatives of the Formulae I and IA are employed in the treatment and control of allergic conditions such as allergic asthma. ##STR1##
REFERENCES:
patent: 3978052 (1976-08-01), Stoss et al.
Hafliger et al., Iminodibenzyl and Related Compounds, Ciba Geigy, 1985, pp. 35-43.
Gordon, Textbook "Psychopharmacological Agents, 1964, Academic Press, New York, N.Y. pp. 5-8.
March, "Advanced Organic Chemistry", pp. 796-797, John Wiley and Sons, (1985).
Girard Yves
Hamel Pierre
Rokach Joshua
Caruso C. M.
Ford John M.
Merck Frosst Canada Inc.
Mullins J. G.
Pfeiffer H. J.
LandOfFree
Anti-allergic and anti-thromboembolic 6H-dibenz-[b,e][1,4]-oxath does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-allergic and anti-thromboembolic 6H-dibenz-[b,e][1,4]-oxath, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-allergic and anti-thromboembolic 6H-dibenz-[b,e][1,4]-oxath will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2399406